Average Co-Inventor Count = 4.09
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (14 from 3,685 patents)
2. Merck + Co., Inc. (1 from 4,770 patents)
14 patents:
1. 8513253 - α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
2. 8143243 - Compounds for the treatment of hepatitis C
3. 8133884 - Compounds for the treatment of hepatitis C
4. 7786122 - α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
5. 7652004 - Compounds for the treatment of hepatitis C
6. 7642251 - Compounds for the treatment of hepatitis C
7. 7521441 - Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
8. 7473688 - Indolobenzazepine HCV NS5B inhibitors
9. 7456167 - Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
10. 7456165 - HCV NS5B inhibitors
11. 7348425 - Inhibitors of HCV replication
12. 7300936 - α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
13. 7153848 - Inhibitors of HCV replication
14. 6967196 - Sulfonamide compounds and uses thereof